Optimal molecular-targeted therapies as first-line treatment for RAS wild-type, right-sided metastatic colorectal cancer from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

被引：0
|
作者：
Yamazaki, Kentaro
Takeda, Yuriko
Misumi, Toshihiro
Suzuki, Motoko
Wakabayashi, Masashi
Bando, Hideaki
Oki, Eiji
Douillard, Jean-Yves
Punt, Cornelis J. A.
Van Cutsem, Eric
Bokemeyer, Carsten
Venook, Alan P.
Maehara, Yoshihiko
Heinemann, Volker
Cremolini, Chiara
Nakayama, Goro
Andre, Thierry
Shi, Qian
De Gramont, Aimery
Yoshino, Takayuki
机构：
[1] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[2] Natl Canc Ctr Hosp East, Dept Data Sci, Kashiwa, Chiba, Japan
[3] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan
[5] Univ Nantes, Med Sch Nantes, Nantes, France
[6] Univ Med Ctr Utrecht, Utrecht, Netherlands
[7] Univ Hosp Gasthuisberg Leuven, Dept Gastroenterol Digest Oncol, Leuven, Belgium
[8] Katholieke Univ Leuven, Leuven, Belgium
[9] Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol, Hamburg, Germany
[10] Univ Med Ctr Hamburg Eppendorf, Bone Marrow Transplantat Sect Pneumol, Hamburg, Germany
[11] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[12] Kyushu Cent Hosp, Mutual Aid Assoc Publ Sch, Fukuoka, Japan
[13] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 3, Munich, Germany
[14] Univ Hosp Pisa, Dept Oncol, Pisa, Italy
[15] Nagoya Univ, Dept Surg Gastroenterol, Grad Sch Med, Nagoya, Aichi, Japan
[16] Hop St Antoine, Paris, France
[17] Mayo Clin, Dept Quantitat Sci Res, Rochester, MN USA
[18] Franco British Hosp, Dept Med Oncol, Levallois Perret, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3588
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England
    Tikhonova, Irina A.
    Huxley, Nicola
    Snowsill, Tristan
    Crathorne, Louise
    Varley-Campbell, Jo
    Napier, Mark
    Hoyle, Martin
    PHARMACOECONOMICS, 2018, 36 (07) : 837 - 851
  • [2] Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England
    Irina A. Tikhonova
    Nicola Huxley
    Tristan Snowsill
    Louise Crathorne
    Jo Varley-Campbell
    Mark Napier
    Martin Hoyle
    PharmacoEconomics, 2018, 36 : 837 - 851
  • [3] CETUXIMAB IN THE FIRST-LINE TREATMENT OF RAS WILD-TYPE METASTATIC COLORECTAL CANCER WITH LIVER-LIMITED DISEASE
    Souza, P., V
    Zanini, F. E.
    Biglia, L., V
    Kim, H. S.
    Fahham, L.
    VALUE IN HEALTH, 2017, 20 (09) : A875 - A875
  • [4] Clonal selection of RAS mutant metastatic colorectal cancer into RAS wild-type during first-line therapy
    Klein-Scory, S.
    Wahner, I.
    Maslova, M.
    Al-Sewaidi, Y.
    Pohl, M.
    Mika, T.
    Ladigan, S.
    Schroers, R.
    Baraniskin, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S229 - S229
  • [5] Treatment outcome comparisons of first-line targeted therapy in patients with KRAS wild-type metastatic colorectal cancer: A nationwide database study
    Liang, Y.
    Shao, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S272 - S273
  • [6] Treatment outcome comparisons of first-line targeted therapy in patients with KRAS wild-type metastatic colorectal cancer: A nationwide database study
    Liang, Yi-Hsin
    Chen, Kuo-Hsing
    Shao, Yu-Yun
    CANCER MEDICINE, 2023, 12 (14): : 15176 - 15186
  • [7] Association of right-sided colon cancer with poor efficacy of cetuximab in patients with RAS wild-type metastatic colorectal cancer.
    Kim, Dalyong
    Hong, Yong Sang
    Kim, Jeong Eun
    Kim, Kyu-Pyo
    Lee, Jae-Lyun
    Chun, Sung-Min
    Kim, Jihun
    Jang, Se Jin
    Kim, Tae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Real-world survival comparison of second-line treatment strategies for patients with RAS/RAF wild-type, right-sided metastatic colorectal cancer
    Swami, Nishwant
    Hwang, Wei-Ting
    Mamtani, Ronac
    O'Hara, Mark H.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 73 - 73
  • [9] Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients
    Samalin, Emmanuelle
    Mazard, Thibault
    Assenat, Eric
    Rouyer, Magali
    de la Fouchardiere, Christelle
    Guimbaud, Rosine
    Smith, Denis
    Portales, Fabienne
    Ychou, Marc
    Adenis, Antoine
    Fiess, Catherine
    Lopez-Crapez, Evelyne
    Thezenas, Simon
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (08) : 1375 - 1381
  • [10] The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis
    Ciliberto, Domenico
    Staropoli, Nicoletta
    Caglioti, Francesca
    Chiellino, Silvia
    Ierardi, Antonella
    Ingargiola, Rossana
    Botta, Cirino
    Arbitrio, Mariamena
    Correale, Pierpaolo
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 : 69 - 77
12345